The translational value of ligand‐receptor binding kinetics in drug discovery
British Journal of Pharmacology · 2024-11 · 181 (21) · 4117-4129
DOI: 10.1111/bph.16241 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift British Journal of Pharmacology, online erschienen am 30.09.2023. Verfasst von Hongli Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, China. Hauptthemen laut MEDLINE: Drug Discovery. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Major Basic Research Project of the Natural Science Research Foundation of the Jiangsu Higher Education Institutions.
Abstract (Originalsprache)
The translation of in vitro potency of a candidate drug, as determined by traditional pharmacology metrics (such as EC 50 /IC 50 and K D /K i values), to in vivo efficacy and safety is challenging. Residence time, which represents the duration of drug‐target interaction, can be part of a more comprehensive understanding of the dynamic nature of drug‐target interactions in vivo, thereby enabling better prediction of drug efficacy and safety. As a consequence, a prolonged residence time may help in achieving sustained pharmacological activity, while transient interactions with shorter residence times may be favourable for targets associated with side effects. Therefore, integration of residence time into the early stages of drug discovery and development has yielded a number of clinical candidates with promising in vivo efficacy and safety profiles. Insights from residence time research thus contribute to the translation of in vitro potency to in vivo efficacy and safety. Further research and advances in measuring and optimizing residence time will bring a much‐needed addition to the drug discovery process and the development of safer and more effective drugs. In this review, we summarize recent research progress on residence time, highlighting its importance from a translational perspective.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, China.
- Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research (LACDR), Leiden University, Leiden, The Netherlands.
ORCID-Profile: Dong Guo
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- Major Basic Research Project of the Natural Science Research Foundation of the Jiangsu Higher Education Institutions
- Major Basic Research Project of the Natural Science Foundation of the Jiangsu Higher Education Institutions
Zitieren
APA
Liu, H., Zhang, H., IJzerman, A. P., & Guo, D. (2024). The translational value of ligand‐receptor binding kinetics in drug discovery. British Journal of Pharmacology, 181(21), 4117-4129. https://doi.org/10.1111/bph.16241
Vancouver
Liu H, Zhang H, IJzerman AP, Guo D. The translational value of ligand‐receptor binding kinetics in drug discovery. British Journal of Pharmacology. 2024;181(21):4117-4129. doi:10.1111/bph.16241
BibTeX
@article{Liu2024,
author = {Liu, Hongli and Zhang, Haoran and IJzerman, Adriaan P and Guo, Dong},
title = {The translational value of ligand‐receptor binding kinetics in drug discovery},
journal = {British Journal of Pharmacology},
year = {2024},
volume = {181},
number = {21},
pages = {4117--4129},
doi = {10.1111/bph.16241}
}
EUVIMED